Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001185185-25-001023
Filing Date
2025-08-19
Accepted
2025-08-18 18:56:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A igcdefa14a081825.htm DEFA14A 34370
2 GRAPHIC image_001.jpg GRAPHIC 6460
3 GRAPHIC image_002.jpg GRAPHIC 49987
4 GRAPHIC image_003.jpg GRAPHIC 10538
5 GRAPHIC image_004.jpg GRAPHIC 2236
  Complete submission text file 0001185185-25-001023.txt   131327
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-32830 | Film No.: 251229254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)